FDA Reconsiders Weight Loss Drug Qnexa

The FDA is once again considering approval of an experimental weight loss drug it rejected a year ago over concerns about potential heart problems and birth defects in babies born to women who take it.

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.

WTVQ.com supports children's privacy rights. All persons under the age of 13 MUST have parental permission to use this website and direct parental supervision is strongly recommended.